The Drainage, Irrigation and Fibrinolytic Trial for post-haemorrhagic hydrocephalus in newborn infants

ISRCTN ISRCTN80286058
DOI https://doi.org/10.1186/ISRCTN80286058
Secondary identifying numbers N/A
Submission date
01/09/2005
Registration date
08/09/2005
Last edited
23/07/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Neonatal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Study website

Contact information

Prof Andrew Whitelaw
Scientific

Neonatal Medicine
University of Bristol Medical School
Southmead Hospital
Bristol
BS10 5NB
United Kingdom

Phone +44 (0)117 959 5699
Email andrew.whitelaw@bristol.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleThe Drainage, Irrigation and Fibrinolytic Trial for post-haemorrhagic hydrocephalus in newborn infants: a randomised controlled trial
Study acronymDRIFT
Study hypothesisIn infants with post-haemorrhagic ventricular dilatation, treatment by drainage, irrigation and fibrinolytic therapy reduces ventriculoperitoneal shunt surgery and disability at 2 years when compared to best standard therapy.

On 11/02/2009 the following changes were made to the trial record:
1. The overall trial start date was changed from 28/02/2003 to 01/02/2003.
2. The overall trial end date was changed from 30/06/2009 to 28/02/2009.
Ethics approval(s)Southmead Local Research Ethics Committee, 28/01/2003, ref: 134/02
ConditionPost-haemorrhagic ventricular dilatation
InterventionDrainage, irrigation and fibrinolytic therapy versus best standard therapy
Intervention typeMixed
Primary outcome measure1. Ventriculoperitoneal shunt surgery
2. Disability at 2 years post-term
Secondary outcome measures1. Secondary haemorrhage
2. Secondary central nervous system (CNS) infection
3. Death before 2 years post-term
4. Hospital admissions by 2 years of age
Overall study start date01/02/2003
Overall study end date28/02/2009

Eligibility

Participant type(s)Patient
Age groupNeonate
SexBoth
Target number of participants120
Total final enrolment77
Participant inclusion criteria1. Infants of less than 28 days of age
2. Intraventricular haemorrhage
3. Progressive enlargement of ventricles to 4 mm over the 97th centile for width or 1 mm over the 97th centile for diagnonal, thalamo-occipital and third ventricle or enlargement of one ventricle together with midline shift
Participant exclusion criteriaGeneralised bleeding tendency
Recruitment start date01/02/2003
Recruitment end date31/12/2006

Locations

Countries of recruitment

  • England
  • Norway
  • Poland
  • United Kingdom

Study participating centre

University of Bristol Medical School
Bristol
BS10 5NB
United Kingdom

Sponsor information

North Bristol NHS Trust (UK)
Hospital/treatment centre

Frenchay Hospital
Bristol
BS16 1LE
England
United Kingdom

Email annette.clarke@nbt.nhs.uk
ROR logo "ROR" https://ror.org/036x6gt55

Funders

Funder type

Charity

Cerebra (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Location
United Kingdom
James and Grace Anderson Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article phase I trial results 01/04/2003 Yes No
Other publications short term outcomes 01/05/2007 Yes No
Results article results 01/04/2010 Yes No
Results article results 01/02/2019 Yes No
Results article 10-year follow up results 04/07/2020 23/07/2020 Yes No

Editorial Notes

23/07/2020: Publication reference added.
19/02/2019: Publication reference added.